|Join Our Mailing List | Audio Packages | Contact Us | Our Homepage|
Partial List of
From Consolidations to Spinoffs to Rollups --
Private Equity Investing
In Specialty Chemicals Companies
John Y. Televantos
Arsenal Capital Partners
Tuesday, December 6, 2016
8:00 am – 5:00 pm
New York City
INSIGHTS FROM 20 EXPERT SPEAKERS!
John L. Beagle, Grace Matthews Inc.
Thomas E. Blaige, Blaige & Co.
Steven J. Bowen, Maine Pointe LLC
David W. Bradley, Jefferies LLC
Michael B. Fieldstone, Aterian Investment Partners LLC
Robert D. Frost, Lazard Middle Market LLC
Rahul Goyal, Partner, AEA Investors LP
Andy Harris, Accella Corp.
Harris D. Kealey, New Mountain Capital LLC
Frederick V. Loneker, Ramboll Environ
Mark McFadden, CCMP Capital Advisors LP
Ryan J. Meany, Edgewater Capital Partners LP
Federico G. M. Mennella, Lincoln International LLC
Jim Mynaugh, Maine Pointe LLC
Keval Patel, H. I. G. Capital LLC
John L. Pouschine, Pouschine Cook Capital Management LLC
Euan Rellie, BDA Partners
Peter K. Shelton, Benesch
Christopher A. Springer, Alliance Holdings Inc.
Mario Toukan, KeyBanc Capital Markets Inc.
Scott M. Wolff, American Securities LLC
Why are specialty chemical companies such a sweet spot for middle market private equity investors?
Why is the outlook for specialty chemical deals so robust, despite drops in public market valuations and only modest macroeconomic growth?
Register now to attend the Capital Roundtable’s upcoming conference on “Private Equity Investing in Specialty Chemicals Companies,” and you’ll hear conference chairman John Televantos of Arsenal Capital Partners and 20 other speakers address these, and additional questions such as --
Whether you’re experienced or new to these ideas, register now to welcome the insights and knowledge from this Capital Roundtable conference being held in New York City on Tuesday, December 6th.
Consider. Downward pressure on raw materials is causing specialty chemical margins to become more attractive. Low cost oil and gas and chemical feedstocks are forcing commodity prices into steep declines. What’s more, China’s expansions into commodity chemicals -- methanol, benzene, chlorine, propylene, and ethylene – are further driving prices down.
The mega-merger of Dow Chemical and DuPont -- and other similar smaller deals, are part of a consolidation wave sweeping the chemicals sector. These deals are creating middle market opportunities to acquire forced divestitures in agriculture, material sciences, and other areas, due to antitrust rules.
Growing shareholder activism is also shaking up general chemical companies, creating opportunities for middle-market PE investors to acquire spinoffs deemed outside core competencies.
The enormous number of mid-sized specialty chemical firms in segments like coatings, adhesives, and sealants also creates opportunities for platform acquisitions followed by roll-ups that can be executed at attractive multiples, less than five times ebitda.
Look at Taminco Corp., a manufacturer of alkylamines and derivatives that started as a carve-out and grew by doing a roll-up.
Given the level of activity in this fast moving sector, register now so you won’t miss the Capital Roundtable’s upcoming conference on Private Equity Investing in Specialty Chemicals Companies.
Here are three more key reasons to attend this conference --
Click here to receive our best rate -- a savings of $400 on our regular conference rates!
Register Now to Meet John Televantos,
And More Than 20 Other Specialty Chemicals Experts & Investors
John Televantos is a partner at Arsenal Capital and joined the firm in 2006. He heads up the firm’s specialty industrials practice and has served as a director of more than a dozen companies.
A veteran of the chemicals industry, he previously served in senior roles at Aqualon Co., Helious Chemical Co., Foamex International, Lyondell Chemical Co., and Arco Chemical Co., as well as directing research and development at Acela Performance Materials. He earned both a BS and a PhD in chemical engineering at University of London.
Here are three more key reasons to register now so you won’t miss this conference --
Register Now to Form Valuable Contacts
With Colleagues & Professionals
This Capital Roundtable conference is the ideal place to expand your network and open up pathways to future deals. The day’s agenda includes ample time to let you --
Keep in mind this conference is certain to fill up quickly, so you’ll want to register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Sarah Burd today to confirm your attendance at 212-832-7300 ext. 0 or firstname.lastname@example.org.
Click Below to Learn More
Designed to Meet the Needs of GPs, LPs, & Managers of Buyout, Growth Equity, Mezzanine, BDC, and Lending Funds, as Well as Independent Sponsors, Operating Partners, Portfolio Company Managers, and the Bankers, Lawyers, Accountants,
& Other Advisors Who Support Them.
We look forward to having you join us on Tuesday, December 6.
This conference is being produced by The Capital Roundtable, America’s leading conference organization focusing on “need-to-know” information for professionals in the middle-market private equity community. For more information about The Capital Roundtable’s 30 annual conferences and other events and programs, please visit www.capitalroundtable.com.
Speaking & Business Development Opportunities
We offer excellent speaking, marketing, and business development opportunities to reach the middle‑market private equity community. For more details, please contact Kellie Green or Claire Notton at 212-832-7300 or by email at email@example.com or firstname.lastname@example.org.
Have a Question?
Please contact Sarah Burd at email@example.com or 212-832-7300 ext. 0.
Who We Are
This Capital Roundtable conference in midtown, New York City, is all-business, all-targeted, all-designed to be a completely focused day of practical information and revealing insights about specialty chemicals companies. You’ll gain valuable insights from --
John Y. Televantos, Arsenal Capital Partners
Space at this conference is limited, so register as soon as possible to assure yourself a seat. To avoid disappointment, please contact Sarah Burd today to confirm your attendance at 212-832-7300 ext. 0 or firstname.lastname@example.org.
Please note that The Capital Roundtable limits the number of registrants from a single firm to three.
Group Rate -- $995 each, when you register two or more people to attend from the same company.
You can pay by credit card (using the links above) or by check. Mail your check and business card to: New York Business Roundtable Inc., 747 Third Avenue, Suite 200, New York, NY 10017.
Have a special question? Please contact Sarah Burd at email@example.com or 212-832-7300 ext 0.
From time to time, for reasons beyond Capital Roundtable's control, program schedules and speakers become subject to change. We make every effort to announce substantive changes by email to registrants at least 48 hours in advance.
Details provided upon registration
Can't attend but want to hear the program? You can buy the audio package along with the handouts. Purchase the audio package online now.
We offer excellent marketing and business development opportunities to reach the middle‑market private equity community. For more details, please contact Claire Notton at 212-832-7300 ext.117, or by email at firstname.lastname@example.org.
Change Your Mailing Preferences
To change your name or email address, or to select the mailings you wish to receive from us, go to our mailing preferences page.
To unsubscribe from our mailings, go to our unsubscribe page. You may also unsubscribe by replying to this email and putting unsubscribe in the subject line or by writing to us at: Capital Roundtable, 12 East 44th Street, Penthouse, New York, NY 10017.
You are subscribed as [EMAIL]
No part of this text may be reproduced or otherwise published without the express written consent of The Capital Roundtable.
©2016 New York Business Roundtable Inc. All Rights Reserved.